Potential coronavirus therapeutic could be first available for critical cases: CytoDyn CEO
CytoDyn CEO Nader Pourhassan discusses company being in advanced stages of clinical trials for coronavirus antibody treatment.
Created By Sora Templates & Blogger Templates | Gooyaabi Templates
No comments
Post a Comment